BT
Better Therapeutics, Inc.
BTTX · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $5.45K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A EV/EBITDA N/A
P/S N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 173.30%
Asset turnover 0.00x
ROIC 273.72%
Debt
64 /100
Moderate Int. coverage -25.66x
Net debt/EBITDA 0.02x
Current ratio 1.37x
Stability
1 /100
Unstable EPS volatility 167.43%
Profitable years 0
Beta 0.19x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o BTTX
Online
Sector
Healthcare
Industry
Medical - Specialties
CEO
Craig R. Jalbert
Employees
54
Headquarters
San Francisco
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report